Suzuki Eiji 鈴木栄治

… Alternative Names

SUZUKI Eiji 鈴木栄治

Less

Researcher Number	00612897
Other IDs
Affiliation (Current)	2025: 地方独立行政法人神戸市民病院機構神戸市立医療センター中央市民病院(第1診療部、第2診療部、第3診療部, 中央市民病院, 部長 2025: 京都大学, 医学研究科, 准教授
Affiliation (based on the past Project Information) *help	2018 – 2019: 京都大学, 医学研究科, 准教授 2016 – 2017: 京都大学, 医学研究科, 助教 2012 – 2015: 京都大学, 医学(系)研究科(研究院), 助教 2014: 京都大学, 医学研究科, 助教 2011 – 2012: 京都大学, 医学研究科, 助教
Review Section/Research Field	Principal Investigator General surgery / Clinical oncology Except Principal Investigator General surgery / Applied pharmacology
Keywords	Principal Investigator 乳癌 / ADCC / 単球 / ニューロピリン / トラスツズマブ / トランスレーショナルリサーチ / 乳癌脳転移 / 乳がん / 遺伝子発現解析 / 脳転移 / HER2 / 腫瘍微小環境 / トラスツマブ … More Except Principal Investigator … More 乳癌 / 薬理学 / トランスレーショナルリサーチ / 免疫学 / 臨床 / 癌 / ホスト因子 / 免疫チェックポイント阻害剤 / 治療効果予測 / 細胞性免疫 / NK活性 / プラチナ製剤 / トリプルネガティブ乳癌 / Oncology / エピゲノム / 血中循環DNA / リキッドバイオプシー / エピジェネティック / 血中浮遊DNA / エピジェネティクス / 乳がん / 由来 / エピジェネティックス / cfDNA / トラスツズマブ耐性 / ADCC / ＡＤＣＣ / 耐性 / トラスツズマブ / HER2 Less

Analysis of brain metastasis specific role of macrophages in breast cancer microenvironmentPrincipal Investigator
- Principal Investigator
  
  SUZUKI EIJI
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  General surgery
- Research Institution
  Kyoto University
Epigenetic profiling of cfDNA in breast cancer samples
- Principal Investigator
  
  SATO FUMIAKI
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  General surgery
- Research Institution
  株式会社関西メディカルネット(関西電力医学研究所)
  Kyoto University
Pharmacological evaluation in Immune-enhancement of anti-neoplastics
- Principal Investigator
  
  Ishiguro Hiroshi
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Applied pharmacology
- Research Institution
  International University of Health and Welfare
  Kyoto University
A role of NRP-1 expressing immune cells in predictive factor of trastuzumab treatment for breast cancer.Principal Investigator
- Principal Investigator
  
  Suzuki Eiji
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  General surgery
- Research Institution
  Kyoto University
Study for molecular basis of trastuzumab-resistance and the development of novel therapeutic strategies.
- Principal Investigator
  
  SUGIE Tomoharu
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  General surgery
- Research Institution
  Kansai Medical University
  Kyoto University
A role of neuropilin-1 expressing natural killer cells in breast cancer treatmentPrincipal Investigator
- Principal Investigator
  
  SUZUKI Eiji
- Project Period (FY)
  2011 – 2012
- Research Category
  
  Grant-in-Aid for Research Activity Start-up
- Research Field
  
  Clinical oncology
- Research Institution
  Kyoto University

All 2019 2018 2017 2016 2015 2014 2013 2012 Other

All Journal Article Presentation

[Journal Article] Real-time navigation system for sentinel lymph node biopsy in breast cancer patients using projection mapping with indocyanine green fluorescence2018
- Author(s)
  Takada Masahiro、Takeuchi Megumi、Suzuki Eiji、Sato Fumiaki、Matsumoto Yoshiaki、Torii Masae、Kawaguchi-Sakita Nobuko、Nishino Hiroto、Seo Satoru、Hatano Etsuro、Toi Masakazu
- Journal Title
  
  Breast Cancer
  
  Volume: - Issue: 6 Pages: 650-655
- DOI
  10.1007/s12282-018-0868-2
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16H05400, KAKENHI-PROJECT-16K10455
[Journal Article] Gene expression profile of peripheral blood mononuclear cells may contribute to the identification and immunological classification of breast cancer patients2018
- Author(s)
  Suzuki Eiji、Sugimoto Masahiro、Kawaguchi Kosuke、Pu Fengling、Uozumi Ryuji、Yamaguchi Ayane、Nishie Mariko、Tsuda Moe、Kotake Takeshi、Morita Satoshi、Toi Masakazu
- Journal Title
  
  Breast Cancer
  
  Volume: 26 Issue: 3 Pages: 282-289
- DOI
  10.1007/s12282-018-0920-2
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K00416, KAKENHI-PROJECT-17K10546
[Journal Article] Downregulation of neuropilin-1 on macrophages modulates antibody-mediated tumoricidal activity2017
- Author(s)
  Kawaguchi Kosuke、Suzuki Eiji、Nishie Mariko、Kii Isao、Kataoka Tatsuki R.、Hirata Masahiro、Inoue Masashi、Pu Fengling、Iwaisako Keiko、Tsuda Moe、Yamaguchi Ayane、Haga Hironori、Hagiwara Masatoshi、Toi Masakazu
- Journal Title
  
  Cancer Immunology, Immunotherapy
  
  Volume: 66 Issue: 9 Pages: 1131-1142
- DOI
  10.1007/s00262-017-2002-2
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K10546, KAKENHI-PROJECT-15K08362
[Journal Article] Trogocytosis-mediated expression of HER2 on immune cells may be associated with a pathological complete response to trastuzumab-based primary systemic therapy in HER2-overexpressing breast cancer patients2015
- Author(s)
  Suzuki E, Kataoka T, Hirata M, Kawaguchi K, Nishie M, Haga H, Toi M
- Journal Title
  
  BMC Cancer
  
  Volume: 15 Issue: 1 Pages: 39-39
- DOI
  10.1186/s12885-015-1041-3
- NAID
  120005758423
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-24591901, KAKENHI-PROJECT-25461980
[Journal Article] The killer cell Ig-like receptor 2DL4 expression in human mast cells and its potential role in breast cancer invasion.2015
- Author(s)
  Ueshima C, Kataoka TR, Hirata M, Furuhata A, Suzuki E, Toi M, Tsuruyama T, Okayama Y, Haga H
- Journal Title
  
  Cancer Immunol Res
  
  Volume: CIR-14 Pages: 0199-0199
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24591901
[Journal Article] Effects of zoledronic acid and the association between its efficacy and \gamma\delta T cells in postmenopausal women with breast cancer treated with preoperative hormonal therapy: a study protocol2014
- Author(s)
  Sumi E, Sugie T, Yoshimura K, Tada H, Ikeda T, Suzuki E, Tanaka Y, Teramukai S, Shimizu A, Toi M, Minato N
- Journal Title
  
  Journal of Translational Medicine
  
  Volume: 12 Issue: 1 Pages: 310-310
- DOI
  10.1186/s12967-014-0310-2
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-24240042, KAKENHI-PROJECT-24590581, KAKENHI-PROJECT-24591901, KAKENHI-PROJECT-26330037, KAKENHI-PLANNED-24111008
[Presentation] Exploration of metastatic brain tumor microenvironment specific molecular properties of immune cells and breast cancer cells2019
- Author(s)
  Eiji Suzuki; Kei Ishii; Takeshi Kotake; Fengling Pu; Eri Hohokabe; Mariko Nishie; Micio Yoshimura; Masakazu Toi
- Organizer
  Cambridge Healthcare Institute’s 2nd Annual Advancing CNS Biotherapeutics and Crossing the Blood-Brain Barrier
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K10546
[Presentation] Prospective Observational Cohort Study of Real World Chemotherapy Sequence for Metastatic Breast Cancer (KBCRN A001: E-SPEC Study)2018
- Author(s)
  Nakatsukasa K, Kikawa Y, Kotake T, Yamagami K, Tsuyuki S, Yamashiro H, Suwa H, Sugie T, Okuno T, Kato H, Takahara S, Nakayama I, Ogura N, Moriguchi Y, Takada M, Suzuki E, Yoshibayashi H, Ishiguro H, Taguchi T, Toi M
- Organizer
  ESMO 2018 Congress
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K08907
[Presentation] Basal-like 乳がん症例におけるシスプラチン含む術前化学療法の予後への影響に関する後向き解析2017
- Author(s)
  山口絢音、石黒洋、鳥井雅恵、松本純明、川口展子、高田正泰、鈴木栄治、竹内恵、佐藤史顕、戸井雅和
- Organizer
  第25回日本乳癌学会学術総会
- Data Source
  KAKENHI-PROJECT-16H05400
[Presentation] Phase 2 study of Pembrolizumab for metastatic triple-negative breast cancer (mTNBC): Japanese Subgroup Results of KEYNOTE 0862017
- Author(s)
  Hattori M, Tamura K, Mukai H, Miyoshi Y, Masuda N, Suzuki E, Ishiguro H, Ohtani S, Hara F, Shimamoto T, Yamamoto K, Ding Yu, Aktan G, Karantza V, Iwata H
- Organizer
  ESMO Asia 2017 Congress
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K08907
[Presentation] 日本人乳癌患者におけるオランザピン（アプレピタント非併用）の化学療法誘発性悪心嘔吐抑制効果2017
- Author(s)
  西村友美、石黒洋、眞鍋恵理子、河口浩介、木曾末厘乃、鳥井雅恵、松本純明、川口展子、高田正泰、竹内恵、鈴木栄治、佐藤史顕、戸井雅和
- Organizer
  第25回日本乳癌学会学術総会
- Data Source
  KAKENHI-PROJECT-16H05400
[Presentation] 乳癌における乳房切除術後胸壁・所属リンパ節再発に対する放射線療法成績の遡及的検討2017
- Author(s)
  平田希美子、小野幸果、戸井雅和、佐藤史顕、鈴木栄治、竹内恵、高田正泰、吉村通央
- Organizer
  第25回日本乳癌学会学術総会
- Data Source
  KAKENHI-PROJECT-16H05400
[Presentation] Gene expression profile of peripheral blood mononuclear cells in breast cancer patients may contribute to the identification and the immunological classification of breast cancer patients by blood test.2017
- Author(s)
  鈴木栄治
- Organizer
  米国がん学会
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K10546
[Presentation] Cisplatin based preoperative chemotherapy regimens for basal-like breast cancer improve prognosis even in patients without pCR: A retrospective analysis from a single-institution2016
- Author(s)
  Ayane Yamaguchi, Hiroshi Ishiguro, Masae Torii, Masahiro Takada, Eiji Suzuki, Megumi Takeuchi, Fumiaki Sato, Masakazu To
- Organizer
  第 72 回京滋乳癌研究会
- Place of Presentation
  京都大学医学部構内芝蘭会館
- Data Source
  KAKENHI-PROJECT-16K08907
[Presentation] Cisplatin based preoperative chemotherapy regimens for basal-like breast cancer potentially improve prognosis even in patients without pCR: A retrospective analysis from a single-institution2016
- Author(s)
  Yamaguchi A,Ishiguro H,Torii M,Takada M,Suzuki E,Takeuchi M,Sato F,Toi M
- Organizer
  ESMO Asia 2016
- Place of Presentation
  Suntec Singapore Convention &Exhibition Center
- Year and Date
  2016-12-16
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K08907
[Presentation] Proteomics analysis of breast cancer cell-specific proteins that are transferred to immune cells via trogocytosis2016
- Author(s)
  Eiji Suzuki
- Organizer
  AACR
- Place of Presentation
  New Orleans
- Year and Date
  2016-04-16
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25461980
[Presentation] 日本人乳癌患者におけるオランザピン（アプレピタント非併用）の化学療法誘発性悪心嘔吐抑制効果2016
- Author(s)
  西村　友美、石黒　洋、中木村　朋美、福井　由紀子、前川　佳奈、仁尾　万里華、山口　絢音、中山　美恵、林　雪、古武　剛、矢内　勢司、松本　純明、高田　正泰、竹内　恵、鈴木　栄治、佐藤　史顕、戸井　雅和
- Organizer
  第24回日本乳癌学会学術総会
- Place of Presentation
  東京ビックサイト
- Year and Date
  2016-06-16
- Data Source
  KAKENHI-PROJECT-16K08907
[Presentation] 乳腺間質肉腫の２例2016
- Author(s)
  矢内勢司、松本純弘、古武剛、林雪、高田正泰、鈴木栄治、竹内恵、石黒洋、佐藤史顕、戸井雅和
- Organizer
  第24回日本乳癌学会学術総会
- Place of Presentation
  東京ビックサイト
- Year and Date
  2016-06-16
- Data Source
  KAKENHI-PROJECT-16K08907
[Presentation] Loss of HER2 via trogocytosis by CD14+ cells in HER2 overexpressing breast cancer cells are associated with diminishing of trastuzumab mediated antibody dependent cellular cytotoxicity2014
- Author(s)
  鈴木　栄治
- Organizer
  米国癌学会
- Place of Presentation
  サンディエゴ
- Data Source
  KAKENHI-PROJECT-25461980
[Presentation] Loss of HER2 via trogocytosis by CD14+ cells in HER2 overexpressing breast cancer cells are associated with diminishing of trastuzumab mediated antibody dependent cellular cytotoxicity.2014
- Author(s)
  Suzuki E, Nishie M, Kawaguchi K, et al.
- Organizer
  ＡＡＣＲ　ａｎｎｕａl　ｍｅｅｔｉｎｇ
- Place of Presentation
  San Diego, USA
- Data Source
  KAKENHI-PROJECT-24591901
[Presentation] Neurropilin-1 high monocytes play an important role in trastuzumab mediated antibody-dependentcellular cytotoxicity in HER2 positive breast cancer cell lines2013
- Author(s)
  河口浩介、鈴木栄治
- Organizer
  米国癌学会
- Place of Presentation
  ワシントンDC、米国
- Data Source
  KAKENHI-PROJECT-23800036
[Presentation] ヒト乳癌細胞がトラスツズマブを介した抗体依存性細胞傷害活性に対する耐性能を獲得するメカニズムの解明2013
- Author(s)
  鈴木栄治、佐藤史顕、河口浩介、杉江知治、戸井雅和
- Organizer
  日本乳癌学会
- Place of Presentation
  浜松
- Data Source
  KAKENHI-PROJECT-24591901
[Presentation] Upregulation of neuropilin-1 in human monocyte is induced by RANKL and may be associated with trastuzumab mediated antibody dependent cellular cytotoxicity2013
- Author(s)
  鈴木栄治
- Organizer
  米国癌学会
- Place of Presentation
  ワシントンＤＣ
- Data Source
  KAKENHI-PROJECT-23800036
[Presentation] Upregulation of neuropilin-1 in human monocyte is induced by RANKL and may be associated with trastuzumab mediated antibody dependent cellular cytotoxicity2013
- Author(s)
  鈴木栄治
- Organizer
  米国癌学会
- Place of Presentation
  ワシントンDC、米国
- Data Source
  KAKENHI-PROJECT-23800036
[Presentation] Trastuzumabを介した抗体依存性細胞障害活性(ADCC)耐性乳癌細胞株の樹立2012
- Author(s)
  鈴木栄治、佐藤史顕、竹内恵、上野貴之、杉江知治、戸井雅和
- Organizer
  日本乳癌学会
- Place of Presentation
  熊本
- Data Source
  KAKENHI-PROJECT-24591901
[Presentation] Trogocytosis of HER2 overexpressing human breast cancer cell lines
- Author(s)
  Aratake J, Suzuki E, Uehiro N, Kawaguchi K, Tanaka S, Nishie M, Sato F, Toi M
- Organizer
  AACR Annual Meeting 2014
- Place of Presentation
  San Diego, CA, USA
- Year and Date
  2014-04-05 – 2014-04-09
- Data Source
  KAKENHI-PROJECT-24591901
[Presentation] EGFR is transferred from triple negative breast cancer cells to immune cells via trogocytosis and expression of EGFR on immune cells is associated with high tumor grade of triple negative breast cancer patients
- Author(s)
  鈴木栄治
- Organizer
  米国癌学会
- Place of Presentation
  フィラデルフィア
- Year and Date
  2015-04-18 – 2015-04-22
- Data Source
  KAKENHI-PROJECT-25461980
[Presentation] Loss of HER2 via trogocytosis by CD14+ cells in HER2 overexpressing breast cancer cells are associated with diminishing of trastuzumab mediated antibody dependent cellular cytotoxicity.
- Author(s)
  Suzuki E, Nishie M, Kawaguchi K, Tanaka S, Toi M
- Organizer
  AACR Annual Meeting 2014
- Place of Presentation
  San Diego, CA, USA
- Year and Date
  2014-04-05 – 2014-04-09
- Data Source
  KAKENHI-PROJECT-24591901
[Presentation] 乳癌におけるトラスツズマブを介した抗体依存性細胞傷害活性における単球とNK細胞の役割
- Author(s)
  鈴木栄治, 荒武淳一, 河口浩介, 田中　直, 西江万梨子, 平田勝啓, 片岡　竜貴, 戸井雅和
- Organizer
  日本外科学会
- Place of Presentation
  京都・国立京都国際会館・グランドプリンスホテル京都
- Year and Date
  2014-04-03 – 2014-04-05
- Data Source
  KAKENHI-PROJECT-24591901
[Presentation] Down regulation of ATP6V1B1 in HER2-overexpressing human breast cancer cell line leads resistance against trastuzumab mediated antibody dependent cellular cytotoxicity
- Author(s)
  Nishie　Ｍ, Suzuki　E, Kawaguchi K, Sakamoto K, Fukushima Y,Hattori M, Sugie T, Toi M
- Organizer
  AACR Annual Meeting 2015
- Place of Presentation
  Philadelphia, USA
- Year and Date
  2015-04-19 – 2015-04-22
- Data Source
  KAKENHI-PROJECT-24591901
[Presentation] High neuropilin-1 expression on monocytes is positively associated with trastuzumab-mediated antibody-dependent cellular cytotoxicity of the HER2-overexpressing breast cancer cell line
- Author(s)
  Kawaguchi K, Suzuki E, Kawashima M, Toi M
- Organizer
  AACR Annual Meeting 2014
- Place of Presentation
  San Diego, CA, USA
- Year and Date
  2014-04-05 – 2014-04-09
- Data Source
  KAKENHI-PROJECT-24591901

1. SATO Fumiaki (20467426)

# of Collaborated Projects: 3 results

# of Collaborated Products: 7 results
2. SUGIE Tomoharu (70335264)

# of Collaborated Projects: 1 results

# of Collaborated Products: 3 results
3. Ishiguro Hiroshi (20422925)

# of Collaborated Projects: 1 results

# of Collaborated Products: 6 results
4. 戸井雅和 (10207516)

# of Collaborated Projects: 1 results

# of Collaborated Products: 4 results
5. 松村謙臣 (20452336)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
6. 片岡竜貴 (20343254)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
7. TERAMUKAI Satoshi

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
8. SUGIMOTO Masahiro

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Suzuki Eiji 鈴木 栄治

SUZUKI Eiji 鈴木 栄治

Research Projects

Research Products

Co-Researchers

Analysis of brain metastasis specific role of macrophages in breast cancer microenvironmentPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Epigenetic profiling of cfDNA in breast cancer samples

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Pharmacological evaluation in Immune-enhancement of anti-neoplastics

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

A role of NRP-1 expressing immune cells in predictive factor of trastuzumab treatment for breast cancer.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Study for molecular basis of trastuzumab-resistance and the development of novel therapeutic strategies.

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

A role of neuropilin-1 expressing natural killer cells in breast cancer treatmentPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Real-time navigation system for sentinel lymph node biopsy in breast cancer patients using projection mapping with indocyanine green fluorescence2018

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Gene expression profile of peripheral blood mononuclear cells may contribute to the identification and immunological classification of breast cancer patients2018

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Downregulation of neuropilin-1 on macrophages modulates antibody-mediated tumoricidal activity2017

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Trogocytosis-mediated expression of HER2 on immune cells may be associated with a pathological complete response to trastuzumab-based primary systemic therapy in HER2-overexpressing breast cancer patients2015

Author(s)

Journal Title

DOI

NAID

Data Source

[Journal Article] The killer cell Ig-like receptor 2DL4 expression in human mast cells and its potential role in breast cancer invasion.2015

Author(s)

Journal Title

Data Source

[Journal Article] Effects of zoledronic acid and the association between its efficacy and \gamma\delta T cells in postmenopausal women with breast cancer treated with preoperative hormonal therapy: a study protocol2014

Author(s)

Journal Title

DOI

Data Source

[Presentation] Exploration of metastatic brain tumor microenvironment specific molecular properties of immune cells and breast cancer cells2019

Author(s)

Organizer

Data Source

[Presentation] Prospective Observational Cohort Study of Real World Chemotherapy Sequence for Metastatic Breast Cancer (KBCRN A001: E-SPEC Study)2018

Author(s)

Organizer

Data Source

[Presentation] Basal-like 乳がん症例におけるシスプラチン含む術前化学療法 の予後への影響に関する後向き解析2017

Suzuki Eiji 鈴木栄治

SUZUKI Eiji 鈴木栄治

[Presentation] Basal-like 乳がん症例におけるシスプラチン含む術前化学療法の予後への影響に関する後向き解析2017

[Presentation] 乳癌における乳房切除術後胸壁・所属リンパ節再発に対する放射線療法成績の遡及的検討2017

[Presentation] 日本人乳癌患者におけるオランザピン（アプレピタント非併用）の化学療法誘発性悪心嘔吐抑制効果2016